• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Concentration of ondansetron in cerebrospinal fluid following oral dosing in volunteers.

作者信息

Simpson K H, Murphy P, Colthup P V, Whelan P

机构信息

University Department of Anaesthesia, St. James's University Hospital, Leeds, UK.

出版信息

Psychopharmacology (Berl). 1992;109(4):497-8. doi: 10.1007/BF02247730.

DOI:10.1007/BF02247730
PMID:1365869
Abstract

This study measured the concentrations of ondansetron in plasma and cerebrospinal fluid (CSF) in six volunteers after oral dosing to steady state. Ondansetron concentrations ranged from 39.5-147 ng ml-1 in plasma and from 2.6-15.4 ng ml-1 in CSF. There was good correlation between plasma and CSF concentrations (r = 0.89, p = 0.017). CSF concentrations were less than 15% of plasma concentrations in all cases, indicating that the rate of penetration of the blood brain barrier by ondansetron is low.

摘要

相似文献

1
Concentration of ondansetron in cerebrospinal fluid following oral dosing in volunteers.
Psychopharmacology (Berl). 1992;109(4):497-8. doi: 10.1007/BF02247730.
2
High-resolution liquid chromatographic method using ultraviolet detection for determination of ondansetron in human plasma.
J Chromatogr B Biomed Sci Appl. 1997 Jun 6;693(2):399-406. doi: 10.1016/s0378-4347(97)00068-6.
3
Pharmacokinetic Modeling of the Impact of P-glycoprotein on Ondansetron Disposition in the Central Nervous System.P-糖蛋白对昂丹司琼在中枢神经系统中处置影响的药代动力学建模。
Pharm Res. 2020 Sep 28;37(10):205. doi: 10.1007/s11095-020-02929-2.
4
Simultaneous determination of ondansetron and tropisetron in human plasma using HPLC with UV detection.采用带紫外检测的高效液相色谱法同时测定人血浆中昂丹司琼和托烷司琼的含量。
Biomed Chromatogr. 2002 May;16(3):187-90. doi: 10.1002/bmc.125.
5
Pharmacokinetic modeling and Monte Carlo simulation of ondansetron following oral administration in dogs.犬口服昂丹司琼后的药代动力学建模与蒙特卡洛模拟
J Vet Pharmacol Ther. 2015 Apr;38(2):199-202. doi: 10.1111/jvp.12147. Epub 2014 Aug 1.
6
The effect of rifampin on the pharmacokinetics of oral and intravenous ondansetron.利福平对口服和静脉注射昂丹司琼药代动力学的影响。
Clin Pharmacol Ther. 1999 Apr;65(4):377-81. doi: 10.1016/S0009-9236(99)70130-X.
7
Plasma and cerebrospinal fluid pharmacokinetics of ondansetron in humans.昂丹司琼在人体中的血浆和脑脊液药代动力学。
Br J Clin Pharmacol. 2021 Feb;87(2):516-526. doi: 10.1111/bcp.14412. Epub 2020 Jun 30.
8
Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers.在小型猪和健康志愿者中,皮下给予重组人透明质酸酶后昂丹司琼的耐受性和药代动力学特性。
Clin Ther. 2014 Feb 1;36(2):211-24. doi: 10.1016/j.clinthera.2013.12.013. Epub 2014 Jan 31.
9
Quantitative determination of ondansetron in human plasma by enantioselective liquid chromatography-tandem mass spectrometry.采用对映体选择性液相色谱-串联质谱法对人血浆中昂丹司琼进行定量测定。
J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Mar 15;864(1-2):129-36. doi: 10.1016/j.jchromb.2008.02.002. Epub 2008 Feb 12.
10
The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment.肝功能损害患者静脉注射昂丹司琼的药代动力学。
Br J Clin Pharmacol. 1993 Apr;35(4):441-3. doi: 10.1111/j.1365-2125.1993.tb04164.x.

引用本文的文献

1
Differential effects of antiemetic serotonin receptor antagonist Ondansetron on nausea associated with CHRM3 rs2165870 and TACR1 rs3755468 single-nucleotide polymorphisms.抗呕吐血清素受体拮抗剂昂丹司琼对与毒蕈碱型乙酰胆碱受体M3基因rs2165870单核苷酸多态性和速激肽受体1基因rs3755468单核苷酸多态性相关恶心的不同作用。
Mol Brain. 2025 Jul 21;18(1):64. doi: 10.1186/s13041-025-01237-3.
2
Optimizing a therapy for opiate use disorders: Characterizing ondansetron pharmacokinetics in blood and brain.优化阿片类药物使用障碍的治疗方法:在血液和大脑中表征昂丹司琼的药代动力学。
Clin Transl Sci. 2023 Feb;16(2):216-223. doi: 10.1111/cts.13440. Epub 2022 Nov 9.
3

本文引用的文献

1
The determination in plasma and pharmacokinetics of ondansetron.昂丹司琼的血浆测定及药代动力学
Eur J Cancer Clin Oncol. 1989;25 Suppl 1:S71-4.
2
Determination of ondansetron in plasma and its pharmacokinetics in the young and elderly.
J Pharm Sci. 1991 Sep;80(9):868-71. doi: 10.1002/jps.2600800913.
3
A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.静脉注射选择性5-羟色胺拮抗剂昂丹司琼与静脉注射胃复安预防大剂量顺铂化疗相关恶心和呕吐的单盲比较。
The physiological control of eating: signals, neurons, and networks.
进食的生理控制:信号、神经元和网络。
Physiol Rev. 2022 Apr 1;102(2):689-813. doi: 10.1152/physrev.00028.2020. Epub 2021 Sep 6.
4
5-HT3 Antagonist Ondansetron Increases apoE Secretion by Modulating the LXR-ABCA1 Pathway.5-HT3 受体拮抗剂昂丹司琼通过调节 LXR-ABCA1 通路增加 apoE 的分泌。
Int J Mol Sci. 2019 Mar 25;20(6):1488. doi: 10.3390/ijms20061488.
5
Modality selective roles of pro-nociceptive spinal 5-HT and 5-HT receptors in normal and neuropathic states.在正常和病态状态下,脊髓促伤害性 5-HT 及其受体的模式选择性作用。
Neuropharmacology. 2018 Dec;143:29-37. doi: 10.1016/j.neuropharm.2018.09.028. Epub 2018 Sep 18.
6
A Flawed Design Produces Flawed Results.有缺陷的设计会产生有缺陷的结果。
J Addict Med. 2018 May/Jun;12(3):252. doi: 10.1097/ADM.0000000000000394.
7
Low protein diets produce divergent effects on energy balance.低蛋白饮食对能量平衡产生不同的影响。
Sci Rep. 2016 Apr 28;6:25145. doi: 10.1038/srep25145.
8
A Randomized Double-Blind, Double-Dummy, Multicenter Trial of Azasetron versus Ondansetron to Evaluate Efficacy and Safety in the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy.一项评价阿扎司琼与昂丹司琼预防化疗引起的迟发性恶心呕吐的疗效和安全性的随机、双盲、双模拟、多中心试验。
Cancer Res Treat. 2014 Jan;46(1):19-26. doi: 10.4143/crt.2014.46.1.19. Epub 2014 Jan 15.
9
Antidepressant Potential of 5-HT3 Receptor Antagonist, N-n- propyl-3-ethoxyquinoxaline-2-carboxamide (6n).5-羟色胺3型受体拮抗剂N-正丙基-3-乙氧基喹喔啉-2-甲酰胺(6n)的抗抑郁潜力
J Young Pharm. 2012 Oct;4(4):235-44. doi: 10.4103/0975-1483.104367.
10
Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial.格拉司琼辅助氟伏沙明治疗中重度强迫症的随机、双盲、安慰剂对照试验。
CNS Drugs. 2012 Oct 1;26(10):883-92. doi: 10.2165/11635850-000000000-00000.
J Clin Oncol. 1991 May;9(5):721-8. doi: 10.1200/JCO.1991.9.5.721.